Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.
12 April 2019

Xlucane Product Launch Insight with STADA and Xbrane Biopharma

Vator Securities hosted a Product Launch Insight event for Xlucane together with German STADA Arzneimittel and Xbrane Biopharma yesterday, 11 April 2019.

EVP Global Communications Frank Staud and Director Global Biosimilars Patrick Schlebrowski presented STADAS Biosimilar strategy, market expectations, pipeline and a more detailed look at Xlucane (co-dev by Xbrane/STADA) product launch.

Presenting at the event were Patrick Schlebrowski and Frank Staud from STADA together with Xbrane’s Chairman Anders Tullgren and Martin Åmark, CEO.

Watch the presentation here.